Vaccinations, oral hygiene, and diabetes medications play a key role in dementia prevention.
Proven Protective Effects of Vaccination
A study published in June 2026 in the Annals of Internal Medicine by Brown University presents impressive data. Researchers examined over 500,000 Medicare participants aged 66 and older. The results showed that vaccination with Shingrix reduced the risk of dementia by 24 percent. Over a four-year observation period, 18.8 percent of vaccinated individuals developed dementia, compared to 24.6 percent in the unvaccinated group. A further study from Wales confirmed this trend, indicating a 20 percent risk reduction over seven years with the older vaccine Zostavax.
The Importance of Oral Hygiene
Chronic periodontitis is emerging as a significant risk factor for dementia. This is due to bacteria such as Porphyromonas gingivalis entering the bloodstream and causing inflammation in the brain. The Fraunhofer Institute for Cell Therapy and Immunology (IZI) has identified a compound that blocks this pathogen without harming the healthy oral flora. The spin-off PerioTrap has already launched toothpaste and care gel targeting this issue.
A U.S. study with over 90,000 participants underscores the importance of dental care. Financial barriers to visiting the dentist not only increase the risk of cardiovascular diseases but also of dementia. Up to four percent of these diseases could be prevented with better access to dental care. Alongside personal hygiene, the targeted activation of brain cells is also crucial for prevention. This free guide offers 11 practical everyday exercises to enhance mental fitness and actively prevent dementia.
Diabetes Medications Yield Unexpected Benefits
In the realm of medical prevention, diabetes treatments are gaining attention. A study presented by the NIH in June 2026 revealed that SGLT2 inhibitors reduce the risk of Alzheimer’s by 43 percent among diabetics. Additionally, GLP-1 agonists showed a 33 percent reduction. However, not all medications have a positive impact. Experts warn against anticholinergics, which can increase dementia risk by up to 54 percent. Proton pump inhibitors like Omeprazole have been associated with a 44 percent increase. Blood pressure also plays a crucial role, with hypertension raising Alzheimer’s risk by 1.57 times and hypotension increasing it by 2.74 times.
AI Capabilities in Early Alzheimer’s Detection
Early detection methods are making significant strides. AI-based retinal scans can identify Alzheimer’s risk up to 8.55 years before clinical symptoms appear. The market for these technologies is rapidly expanding, projected to grow from $2.65 billion in 2023 to $9.4 billion by 2033. Complementing this are high-precision blood tests. The pTau217 test, already CE-marked, can detect amyloid pathology with over 90 percent accuracy in just 17 minutes.
Because early warning signs can be challenging to interpret, an objective assessment of one’s situation is beneficial. This expert-developed 7-question test allows you to receive an anonymous evaluation of your cognitive performance via email in just 2 minutes.
Lifestyle as a Critical Factor
In addition to medical and technological approaches, lifestyle choices remain central. Research findings from June 2026 indicate that specific gene variants (AQP4) amplify the negative effects of sleep deprivation on gray matter. Sleep apnea can increase the risk of dementia by 34 percent. However, there’s good news as well: the use of hearing aids in epilepsy patients with hearing loss has been shown to lower dementia risk by 23 percent, according to results presented at a scientific conference in spring 2026.
